Comprehensive Notes on Glucose Metabolism, Glycolysis, and Gluconeogenesis
Glucose Metabolism Overview
Glycolysis: This process involves the breakdown of glucose into pyruvate to yield energy.
Gluconeogenesis: This pathway involves the combination of smaller carbon-containing compounds to synthesize glucose.
Glycogen Synthesis and Breakdown: This involves the storage of glucose as a glycogen polymer or the recovery of glucose from that polymer.
Glycolysis: Step-by-Step Pathway
Glycolysis occurs in a total of 10 enzymatic steps. A six-carbon glucose molecule is broken down into two three-carbon pyruvate molecules.
Energy Investment Phase (Steps 1–5):
During this phase, ATP molecules are hydrolyzed to ADP for every glucose molecule.
Energy Payoff Phase (Steps 6–10):
ATP molecules are generated per glucose, resulting in a net gain of ATP.
electron carriers are reduced to NADH.
NADH can subsequently be oxidized in the Electron Transport Chain to generate additional ATP.
Step 1: Hexokinase Reaction
Kinases are enzymes that phosphorylate molecules.
ATP is invested in this reaction; ATP hydrolysis drives it forward.
The reaction is irreversible.
Glucose 6-phosphate (G6P) is produced. This molecule is an intermediate for several metabolic pathways and is not yet committed specifically to glycolysis.
Step 2: Phosphoglucose Isomerase Reaction
This reaction involves the conversion of an aldose (glucose) to a ketose (fructose).
It transitions the molecule from a pyranose ring to a furanose ring.
This reaction is near equilibrium and is reversible.
The molecule is still not committed to the glycolysis pathway.
Step 3: Phosphofructokinase-1 (PFK-1) Reaction
A second ATP molecule is invested, and ATP hydrolysis drives the reaction.
This reaction is irreversible.
First Committed Step: This is the first committed step of glycolysis and is highly regulated.
Step 4: Aldolase Reaction
Fructose 1,6-bisphosphate exists in both ring and linear forms within the cell. The linear form is useful for visualizing the cleavage into two three-carbon sugars.
The aldolase reaction acts as the reverse of an aldol condensation.
One six-carbon glucose derivative is broken into two three-carbon sugars.
Mechanism Details:
Nucleophilic attack of the carbonyl by the lysine amine yields a covalent intermediate.
Loss of water completes the formation of a Schiff Base (covalent catalysis).
Tyrosine abstracts a proton from the alcohol (base catalysis).
Cleavage of the bond releases Glyceraldehyde 3-phosphate (GAP).
Tyrosine protonates , reforming the Schiff base (acid catalysis).
Hydrolysis of the Schiff base regenerates the active site and releases Dihydroxyacetone phosphate (DHAP).
Step 5: Triose Phosphate Isomerase Reaction
This is the reversible interconversion of DHAP to GAP.
Two GAP molecules proceed through the remainder of the glycolytic pathway.
While ΔG > 0 for the DHAP to GAP conversion, the reaction proceeds forward because GAP is consumed immediately in Step 6.
At equilibrium, of molecules are DHAP and are GAP.
Diffusion Limited: Triose phosphate isomerase is considered a "perfect" enzyme because its rate of catalysis is limited only by diffusion.
The enzyme provides significant transition state stabilization through conformational changes upon binding.
Step 6: GAP Dehydrogenase Reaction
This reaction is both a phosphorylation and an oxidation-reduction reaction.
The phosphate does not come from ATP; the reaction proceeds through a high-energy thioester intermediate.
is reduced to NADH.
The reaction is strongly inhibited by , which competes with for the enzyme binding site.
Step 7: Phosphoglycerate Kinase Reaction
ATP is generated through substrate-level phosphorylation.
Because there are two 1,3-BPG molecules per glucose, this reaction occurs twice. At this point, the initial ATP invested have been recovered, making the net yield of ATP zero.
Step 8: Phosphoglycerate Mutase Reaction
The phosphate group is moved from to .
Moving the phosphate closer to the carboxylic acid increases the energy of the phosphoester bond.
The reaction is catalyzed by a phosphorylated histidine at the active site, and the carboxylic acid is stabilized by an adjacent lysine side chain.
Step 9: Enolase Reaction
Enolase catalyzes a dehydration reaction to yield the enol form of the substrate (Phosphoenolpyruvate or PEP).
The phosphorylated enol is a high-energy species with enough energy to transfer the phosphate to ADP.
Step 10: Pyruvate Kinase Reaction
ATP is formed by a second substrate-level phosphorylation.
The final energetic payoff nets ATP per glucose for the full cycle.
The initial product is the enol form of pyruvate, which then tautomerizes into pyruvate.
Thermodynamics and Flux of Glycolysis
Standard Gibbs free energy changes () suggest several steps are disfavored (\Delta G^{o'} > 0).
However, cellular concentrations of metabolites ensure that all reactions are spontaneous (\Delta G < 0) under physiological conditions.
Steps 1, 3, and 10 are irreversible (forward only).
Step 5 is endergonic but driven forward by the GAP concentration gradient.
Gluconeogenesis
Gluconeogenesis is the formation of glucose from pyruvate (via glycolysis) or oxaloacetate (via the TCA cycle).
The pathway utilizes the reversible enzymes of glycolysis but requires four unique enzymes to bypass irreversible steps:
Pyruvate carboxylase
Phosphoenolpyruvate carboxykinase (PEPCK)
Fructose bisphosphatase
Glucose-6-phosphatase
Conversion of Pyruvate to PEP: This is an endergonic process coupled with the hydrolysis of both ATP and GTP. is added in the first step and released in the second.
The final two unique steps of gluconeogenesis are catalyzed by phosphatases.
Regulation of Glycolysis and Gluconeogenesis
If both pathways occurred simultaneously, there would be a net consumption of ATP (GTP is considered equivalent to ATP for energy balancing).
Reciprocal Regulation: Regulation ensures that when one pathway is active, the other is inhibited based on cellular needs.
Fructose-2,6-bisphosphate: This molecule serves as a master switch, regulating both pathways to prevent them from occurring at the same time.
General Mechanisms of Metabolic Regulation
Product Inhibition: The final product of a pathway often allosterically inhibits an enzyme earlier in the pathway to prevent accumulation and save resources.
Feed-Forward Activation: An early product (after the committed step) activates a later enzyme to increase final product formation and clear intermediate backlogs.
Covalent Modification: Post-translational modifications, such as phosphorylation by kinases or dephosphorylation by phosphatases, modulate protein activity. Others include acetylation, methylation, and glycosylation.
Synthesis and Degradation: Changing the amount of enzyme present via protein synthesis or degradation is often induced by hormones. These signals take a long time to take effect but are long-lasting.
Specific Regulatory Points
Hexokinase: In most tissues, it is inhibited by its product, Glucose 6-phosphate. Liver hexokinase IV (glucokinase) is NOT inhibited by G6P, allowing the liver to uptake excess glucose.
Phosphofructokinase-1 (PFK-1): The most highly regulated step.
ATP: Inhibits in most species.
ADP: Activates in bacteria.
AMP: Activates in mammals.
PEP: Inhibits in bacteria.
Citrate: Inhibits in most species.
Fructose-2,6-bisphosphate: Activates in mammals.
AMP vs. ATP: While ATP levels stay relatively stable, AMP levels fluctuate significantly and serve as a sensitive indicator of the cell's energy state.
Pyruvate Kinase: Regulated by feed-forward activation (Fructose 1,6-bisphosphate) and product inhibition (ATP). It is also inactivated by phosphorylation by Protein Kinase A (PKA).
Signal Transduction and Hormonal Control
G-Protein Coupled Receptors (GPCR)
GPCRs are protein complexes consisting of a receptor and a multi-subunit G-protein (, , and subunits).
G-Protein Cycle:
Ligand binding induces the subunit to release GDP and bind GTP, causing it to dissociate from the receptor and the complex.
The GTP-bound subunit is active and modulates effector enzymes, often adenylate cyclase.
The native GTPase activity of the subunit eventually hydrolyzes GTP back to GDP, allowing the subunit to reassociate with the complex.
Secondary Messengers and PKA
Adenylate Cyclase: Converts ATP to cyclic AMP (cAMP).
Protein Kinase A (PKA): A heterotetramer of two regulatory (R) and two catalytic (C) domains. cAMP binding to the R domains releases active C subunits.
Signal Termination: cAMP is hydrolyzed to AMP by phosphodiesterase to inactivate the response.
Epinephrine and Glucagon Signaling
Epinephrine (Fight or Flight): Acts via -Adrenergic receptors. It activates PKA, which ultimately activates glycogen phosphorylase to break down glycogen into glucose for energy.
Glucagon: Indicates low blood sugar. It uses the cAMP/PKA pathway to phosphorylate the bifunctional PFK-2/FBPase-2 enzyme.
PFK-2 / FBPase-2: Phosphorylation by PKA inactivates PFK-2 and activates FBPase-2. This drops F-2,6-BP levels, reducing glycolytic activation and stimulating gluconeogenesis.
Insulin and Tyrosine Kinase Receptors
Insulin: Indicates high blood sugar. It binds to a receptor tyrosine kinase, inducing autophosphorylation.
Activation Cascade: Triggers a cascade activating Protein Kinase B (PKB) and Protein Kinase C (PKC).
Response: Activates glycogen synthesis and stimulates the translocation of glucose transporters to the cell surface to increase glucose uptake.
Metabolism of Other Sugars
Galactose: Reacts with UDP-glucose to form UDP-galactose (via Galactose 1-phosphate). It is then converted into Glucose 6-phosphate.
Mannose: Phosphorylated to mannose 6-phosphate and converted by phosphomannose isomerase into Fructose 6-phosphate.
Fructose:
Muscle/Kidney/Small Intestine: Converted to Fructose 6-phosphate by Hexokinase (Isoforms I-III).
Liver: Glucokinase (Hexokinase IV) cannot phosphorylate fructose at . Instead, fructose is phosphorylated at to Fructose 1-phosphate and cleaved by a specific aldolase to yield DHAP and glyceraldehyde.
Fates of Pyruvate
Acetyl-CoA: Pyruvate is oxidized and decarboxylated into a two-carbon fragment with a high-energy thioester bond. It enters the TCA cycle or is converted to fatty acids.
Oxaloacetate: A key metabolite for the TCA cycle, gluconeogenesis, and amino acid biosynthesis.
Lactate (Anaerobic in Muscles): Reduced by NADH to regenerate for continued glycolysis. The Cori Cycle involves transporting this lactate to the liver to be converted back into glucose.
Ethanol (Fermentation): Yeast and other organisms regenerate by converting pyruvate to ethanol. Humans metabolize ingested ethanol into acetate in the liver, generating NADH, which can stimulate fatty acid synthesis.
Glycogen Metabolism
Synthesis: Glucose 6-phosphate is converted to Glucose 1-phosphate by phosphoglucomutase. It reacts with UTP to form UDP-glucose (driven by pyrophosphate hydrolysis). Glycogen synthase adds the glucose to the chain.
Breakdown (Glycogenolysis):
Linear Chains: Broken down via phosphorolysis.
Branched Chains: Broken down via hydrolysis.
Entering glycolysis at Step 2 (as G6P) saves one ATP compared to using glucose from the bloodstream, offsetting the energy cost of glycogen synthesis.
The Pentose Phosphate Pathway (PPP)
Functions: Produces NADPH for anabolic reactions/detoxification and Ribose for nucleic acids.
Stages:
Oxidative Stage: Sugar is oxidized and decarboxylated, yielding NADPH.
Non-oxidative Stage: Interconversion of three ribulose-5-phosphate () into two fructose-6-phosphate () and one glyceraldehyde-3-phosphate ().
NADPH vs. NADH
NADPH: Kept at a high NADPH/ ratio. Used as reducing power for biosynthesis and for detoxifying Reactive Oxygen Species (ROS) by reducing glutathione.
NADH: Kept at a low NADH/ ratio. Mainly used in catabolic reactions for energy production.
Glucose-6-Phosphate Dehydrogenase (G6PDH) Deficiency
This is the most common human enzyme defect, affecting over million people. It is X-chromosome linked.
Symptoms: Hemolysis (breakdown of red blood cells) because RBCs rely on a single G6PDH isoform for protection against oxidation during oxygen transport.
Triggers: Antimalarial drugs (primaquine, chloroquine), sulfonamides, aspirin, and henna.
Evolutionary Advantage: Confers resistance against the malaria parasite.
Miscellaneous Details
2,3-Bisphosphoglycerate (2,3-BPG): When glycolysis levels are high, 1,3-BPG is converted to 2,3-BPG by bisphosphoglycerate mutase to regulate delivery.
Caffeine: Inhibits phosphodiesterase (keeping cAMP levels high to persist adrenaline signals) and blocks adenosine receptors in the brain to inhibit sedative effects.